Edition:
United Kingdom

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

60.16EUR
14 Dec 2018
Change (% chg)

€-1.30 (-2.12%)
Prev Close
€61.46
Open
€60.86
Day's High
€60.98
Day's Low
€59.90
Volume
1,307,853
Avg. Vol
928,921
52-wk High
€93.82
52-wk Low
€59.90

Latest Key Developments (Source: Significant Developments)

Fresenius Medical Care AG & Co. KGaA Gives Early Preliminary Indicative Guidance For 2019
Thursday, 6 Dec 2018 

Dec 6 (Reuters) - Fresenius Medical Care AG & Co KGaA ::DGAP-ADHOC: FRESENIUS MEDICAL CARE AG & CO. KGAA GIVES EARLY PRELIMINARY INDICATIVE GUIDANCE FOR 2019.FOR 2019, CO CURRENTLY BROADLY ASSUMES SOLID COMPARABLE REVENUE GROWTH AND COMPARABLE NET INCOME TO BE AROUND LEVEL OF FY 2018.FRESENIUS MEDICAL CARE IS CURRENTLY REVIEWING ALL FACTORS AS PART OF ITS BUDGETING PROCESS.  Full Article

Fresenius Medical Care CEO Says Actively Evaluating M&A Opportunities
Tuesday, 30 Oct 2018 

Oct 30 (Reuters) - Fresenius Medical Care AG & Co KGaA ::FRESENIUS MEDICAL CARE CFO SAYS WE CONTINUE TO ACTIVELY EVALUATE M&A OPPORTUNITIES.FRESENIUS MEDICAL CARE CEO SAYS DOES NOT EXPECT TO NEED TO DO FURTHER DISPOSALS TO CLOSE NXSTAGE DEAL.  Full Article

Fresenius Medical Care Says Gregor Zuend Appointed For Supervisory Board
Monday, 29 Oct 2018 

Oct 29 (Reuters) - Fresenius Medical Care AG & Co KGaA ::SAYS GREGOR ZUEND APPOINTED FOR SUPERVISORY BOARD OF FRESENIUS MEDICAL CARE.  Full Article

FMC Affirms FY Guidance After Q2 Results
Tuesday, 31 Jul 2018 

July 31 (Reuters) - Fresenius Medical Care AG & Co KGaA ::SAYS Q2 SALES 4.214 BILLION EUROS.Q2 EBIT 568 MILLION EUROS.Q2 ADJUSTED. NET INCOME 308 MILLION.CONFIRMS FULL-YEAR GUIDANCE.  Full Article

Fresenius Announces Immediate Availability In U.S. Of Adenosine Injections
Tuesday, 10 Jul 2018 

July 10 (Reuters) - Fresenius Medical Care AG & Co KGaA ::FRESENIUS KABI SAYS ANNOUNCED IMMEDIATE AVAILABILITY IN U.S. OF ADENOSINE INJECTION, USP IN 60 MG PER 20 ML AND 90 MG PER 30 ML PRESENTATIONS.  Full Article

Fresenius Medical Care says places 500 mln eur notes
Wednesday, 4 Jul 2018 

July 4 (Reuters) - Fresenius Medical Care AG & Co KGaA ::SAYS SUCCESSFULLY PLACES €500 MILLION EURO NOTES.SAYS NOTES HAVE A MATURITY OF 7 YEARS AND AN ANNUAL COUPON OF 1.5%. THE ISSUE PRICE IS 99.704% AND THE RESULTING YIELD AMOUNTS TO 1.545%.  Full Article

FMC Appoints Dieter Schenk As New Chairman Of Supervisory Board
Thursday, 17 May 2018 

May 17 (Reuters) - Fresenius Medical Care AG & Co KGaA ::DGAP-NEWS: FRESENIUS MEDICAL CARE FORECASTS CONTINUED STRONG GROWTH - ANNUAL GENERAL MEETING APPROVES 21ST STRAIGHT DIVIDEND INCREASE.CHAIRMAN GERD KRICK SAID HE WILL RESIGN FROM SUPERVISORY BOARD, EFFECTIVE AT MEETING'S END.HAS APPOINTED DIETER SCHENK AS NEW CHAIRMAN OF SUPERVISORY BOARD.  Full Article

Fresenius Medical Care Closes Divestment Of Shiel Medical Laboratory To Quest Diagnostics
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - FRESENIUS MEDICAL CARE AG & CO KGAA ::DGAP-NEWS: FRESENIUS MEDICAL CARE CLOSES DIVESTMENT OF SHIEL MEDICAL LABORATORY TO QUEST DIAGNOSTICS.  Full Article

FMC Q3 impacted by natural disasters in North America
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - FMC AG :‍Says Q3 sales up 3 pct at ‍4.336​ billion eur (+8 pct at constant currency).Says Q3 EBIT flat at ‍609​ million eur (+4 pct at constant currency).Says Q3 net income up 2 pct at ‍309 ​million eur.Says North American business impacted by natural disasters.Says ‍excluding effects from natural disasters, effects of agreement with U.S. Departments of Veterans Affairs and Justice, confirms its full-year outlook 2017​​.Says North America Care Coordination activities grow by 20% (+26 pct at constant currency), margin expands significantly to 7 pct​.Says ‍closing of NxStage deal is currently expected to occur in 2018​.Reuters poll average for FMC q3 net revenue was 4.41 billion eur, EBIT 611 million eur, net income 297 million eur.  Full Article

UPDATE 2-Fresenius plunges as health firm warns investment to hit profit

* Shares plunge 18 percent, poised for biggest one-day drop (Adds analyst comment, loss in market value)